| Literature DB >> 35891995 |
Derya Tatlisuluoglu1, Büşra Tezcan2, İbrahim Mungan3, Yaşar Alp Çakirli1, Naim Boran Tümer4, İrfan Taşoğlu4.
Abstract
Introduction: Coronary artery bypass grafting (CABG) plays an important role in the revascularization of ischemic heart disease. However, stroke is a rare but extremely serious complication after CABG. Aim: We investigated the relationship between platelet-lymphocyte ratio (PLR), neutrophil-lymphocyte ratio, red blood cell distribution width (RDW) values, and postoperative ischemic stroke by examining the preoperative complete blood count (CBC) parameters in patients who underwent CABG. Material and methods: A total of 1240 patients who underwent CABG between September 2016 and June 2019 were included in this retrospective observational study. The diagnosis of ischemic stroke was made in the postoperative period by neurology consultation and radiological imaging. The CBC data used as preoperative values for each case were obtained the day before surgery.Entities:
Keywords: coronary artery bypass grafting; ischemic stroke; neutrophil-lymphocyte ratio; platelet-lymphocyte ratio; red blood cell distribution width
Year: 2022 PMID: 35891995 PMCID: PMC9290396 DOI: 10.5114/kitp.2022.117499
Source DB: PubMed Journal: Kardiochir Torakochirurgia Pol ISSN: 1731-5530
Clinical characteristics of subjects (mean ± SD, n (%))
| Parameter | All ( | IS – ( | IS + ( | |
|---|---|---|---|---|
| Age | 60.41 ±7.23 | 60.27 ±7.02 | 64.65 ±11.20 | < 0.001 |
| Gender (male) | 1070 | 1040 (86.7) | 30 (75) | 0.035 |
| Operation duration [min] | 237.75 ±57.01 | 236 ±52.42 | 290.10 ±126.01 | < 0.001 |
| MV duration [days] | 1.69 ±7.59 | 1 ±0 | 22.40 ±37.09 | < 0.001 |
| ICU duration [days] | 3.11 ±7.93 | 2.30 ±1.00 | 27.45 ±36.64 | < 0.001 |
| Hospital duration [days] | 9.88 ±10.94 | 9.2 ±8.32 | 30.40 ±35.056 | < 0.001 |
| < 35 EF (%) | 4 (0.322) | 0 | 4 (10) | 0.409 |
| Pre-operative neurological disease (%) | 46 (3.70) | 40 (3.33) | 6 (15) | < 0.001 |
| HL (%) | 944 (76.12) | 920 (7.66) | 24 (60) | 0.015 |
| HT (%) | 746 (60.16) | 720 (60) | 26 (65) | 0.520 |
| DM (%) | 452 (36.45) | 440 (36.6) | 12 (30) | 0.389 |
| AF (%) | 244 (19.67) | 240 (20) | 4 (10) | 0.118 |
| Statin use (%) | 940 (75.80) | 920 (76.66) | 20 (50) | < 0.001 |
| Acetylsalicylate (%) | 1182 (95.12) | 1158 (96.5) | 24 (60) | < 0.001 |
| Other antiaggregant (%) | 40 (3.22) | 36(3) | 4 (10) | < 0.001 |
| Smoking (%) | 784 (63.22) | 760 (63.33) | 24 (60) | 0.660 |
| Mortality (%) | 32 (2.58) | 16 (1.33) | 16 (40) | < 0.001 |
| AKF (%) | 10 (0.80) | 0 | 10 (25) | < 0.001 |
| Tracheostomy (%) | 12 (0.96) | 0 | 12 (30) | < 0.001 |
| Postoperative pneumonia (%) | 42 (3.38) | 40 (3.33) | 2 (5) | 0.560 |
| Postoperative infection (%) | 230 (18.54) | 200 (16.66) | 30 (75) | < 0.001 |
SD – standard deviation, EF – ejection fraction, MV – mechanical ventilation, ICU – intensive care unit, HL – hyperlipidemia, HT – hypertension, DM – diabetes mellitus, AF – atrial fibrillation, AKF – acute kidney failure, IS – ischemic stroke.
Hemogram values (mean ± SD)
| Parameter | All ( | IS – ( | IS + ( | |
|---|---|---|---|---|
| Hb [mg/dl] | 14.42 ±1.52 | 14.48 ±1.47 | 12.87 ±2.09 | < 0.001 |
| Platelet [× 109/l] | 266.42 ±79.12 | 255 ±76.58 | 289.75 ±93.80 | 0.053 |
| MPV [fl] | 9.64 ±0.88 | 9.64 ±0.87 | 9.42 ±1.22 | 0.110 |
| PDW [fl] | 13.42 ±2.76 | 13.40 ±2.75 | 13.99 ±3.01 | 0.182 |
| WBC [× 109/l] | 8.63 ±2.12 | 8.63 ±2.12 | 8.65 ±2.36 | 0.953 |
| Lymphocyte [× 109/l] | 2.65 ±1.67 | 2.67 ±1.29 | 2.64 ±3.66 | < 0.001 |
| PLR | 111.5 ±146.18 | 109.66 ±042.52 | 167.09 ±94.32 | < 0.001 |
| NLR | 2.32 ±1.01 | 2.29 ±0.93 | 3.43 ±2.21 | < 0.001 |
| RDW [fl] | 256.22 ±78.07 | 255 ±77.38 | 279.75 ±94.90 | 0.053 |
SD – standard deviation, Hb – hemoglobin, MPV – mean platelet volume, PDW – platelet distribution width, PLR – platelet-lymphocyte ratio, RDW – red blood cell distribution, IS – ischemic stroke.
Multivariate logistic regression
| Parameter | Multivariate logistic regression | ||
|---|---|---|---|
| OR | 95% CI | ||
| Gender | 0.51 | 0.12–2.02 | 0.340 |
| Age | 1.11 | 1.03–1.19 | 0.006 |
| Hb | 0.72 | 0.52–0.99 | 0.050 |
| Operation duration | 1.01 | 1.00–1.02 | < 0.001 |
| Statin use | 0.44 | 0.112–1.823 | 0.082 |
| HL | 0.71 | 0.35–1.01 | 0.059 |
| NLR | 2.02 | 1.39–2.95 | < 0.001 |
| PLR | 1.01 | 1.00–1.02 | 0.014 |
| RDW | 1.73 | 1.23–2.44 | 0.002 |
OR – odds ratio, Hb – hemoglobin, HL – hyperlipidemia, NLR – neutrophil-lymphocyte ratio, PLR – platelet-ymphocyte ratio, RDW – red blood cell distribution.
Figure 1RDW, area under the curve (AUC): 0.696
Figure 2PLR, area under the curve (AUC): 0.703
Figure 3NLR, area under the curve (AUC): 0.684